Abstract
dc:description.abstractIBD 100 proclaims itself to be the number one investing strategy and that it has yielded far better returns since its inception than S&P500 during the same period. I examine the validity of these claims by analyzing the performance of IBD100 stock recommendations made between July2005 and Dec 2009. Although IBD yielded 5.54% in comparison to -8.18% by S&P500 during the study period, deeper analysis of the relative performance to the benchmark index reveals that IBD100 stock are smaller and more growth oriented than those of S&P500 and that when comparing the returns of the IBD 100 to more appropriate benchmarks, the excess performance disappears.
Degree
thesis:*- Level thesis:degree_level
- Master's Degree
- Department thesis:degree_department
- Business Administration
- Year dc:date.issued
- 2010
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Gulati, Bharman
- Advisor dc:contributor.advisor
-
- Stone, Gregory R.
- Committee members dc:contributor.committeemember
-
- Bhargava, Rahul
- Nichols, Mark W
Subjects
dc:subject × 6Rights
dc:rights- Statement dc:rights
-
- In Copyright(All Rights Reserved)
- Author(s)
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/11714/4381